Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Subscribe
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Ipsen Pharmaceuticals
Pharma
Ipsen's Onivyde turns in positive results in pancreatic cancer
The treatment improved progression-free survival by a median of 7.4 months compared with standard of care treatment.
Zoey Becker
Jan 20, 2023 11:21am
'The Top Line': FDA's drug approval, plus this week's headlines
Jan 13, 2023 6:00am
Ipsen's Onivyde pushes for earlier pancreatic cancer
Nov 9, 2022 12:16pm
PanCAN taps Mindy Kaling as face of 'PurpleStride' fundraiser
Mar 1, 2022 9:40am
Ipsen may have found a buyer for its consumer health care unit
Feb 11, 2022 9:13am
JPM22, Day 3: Perrigo, Bausch, Bluebird, Samsung, Novartis
Jan 12, 2022 5:28am
